Lisha Thomas
Family · League City, TXNPI 1174117105
Payments from drug & device makers
Across 132 payments — averaging $22.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$486
- AstraZeneca$356
- AbbVie$277
- Novo Nordisk$245
- Nestle Healthcare Nutrition Inc.$201
- Bayer$183
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,84396%
- Gifts$1194%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 21 | $486 |
| AstraZeneca | 12 | $356 |
| AbbVie | 18 | $277 |
| Novo Nordisk | 9 | $245 |
| Nestle Healthcare Nutrition Inc. | 10 | $201 |
| Bayer | 9 | $183 |
| Mannkind Corporation | 2 | $119 |
| Boehringer Ingelheim | 5 | $115 |
| Inspire Medical Systems, Inc. | 2 | $113 |
| Xeris Pharmaceuticals, Inc. | 7 | $111 |
| Novartis | 4 | $88 |
| Amgen | 4 | $70 |
| Johnson & Johnson(2 entities) | 3 | $69 |
| Mylan Specialty L.p. | 3 | $65 |
| GSK | 3 | $61 |
| Astellas Pharma US Inc | 2 | $39 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $38 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $38 |
| Sun Pharmaceutical Industries Inc. | 2 | $38 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Boston Scientific | 1 | $35 |
| Apellis Pharmaceuticals, Inc. | 1 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $28 |
| Pfizer | 1 | $27 |
| Genentech USA, Inc. | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Scilex Pharmaceuticals Inc. | 1 | $20 |
| CMP Pharma, Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,962 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 22 | $20,765 |
| OzempicSemaglutide | 13 | $19,796 |
| JardianceEmpagliflozin | 15 | $18,910 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 49 | $1,272 |
| Atorvastatin Calcium | 71 | $896 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 25 | $679 |
| Olmesartan Medoxomil | 14 | $595 |
| Gabapentin | 28 | $586 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $480 |
| Rosuvastatin Calcium | 35 | $475 |
| Lisinopril | 54 | $432 |
| Losartan Potassium | 28 | $428 |
| Montelukast Sodium | 14 | $352 |
| Omeprazole | 17 | $345 |
| Tamsulosin Hcl | 15 | $249 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBreztri Aerosphere | $356 | $20,76522 claims |
| Novo NordiskOzempic | $245 | $19,79613 claims |
| Boehringer IngelheimJardiance | $115 | $18,91015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 15,456 family providers in Texas.
Other family in League City
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.